| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.0251 | 41 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.2721 | 23 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.0133 | 37 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.3883 | 19 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.1413 | 28 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.5566 | 11 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.2525 | 57 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.1015 | 7 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 49.4782 | 47 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.1876 | 38 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.9295 | 48 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.4101 | 29 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.101 | 42 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.6451 | 50 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.7671 | 48 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.1972 | 52 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.6133 | 39 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.3421 | 15 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 53.2433 | 57 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.3811 | 24 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.2756 | 38 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.4298 | 39 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.4374 | 50 |